Trials / Completed
CompletedNCT00131430
An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)
An 18-Month Study to Assess the Safety, Tolerability, and Efficacy of MK0364 in Obese Patients
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 500 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A study to determine the safety and efficacy of an investigational drug in patients with obesity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | taranabant |
Timeline
- Start date
- 2005-08-01
- Primary completion
- 2007-05-01
- Completion
- 2007-05-01
- First posted
- 2005-08-18
- Last updated
- 2016-06-07
Source: ClinicalTrials.gov record NCT00131430. Inclusion in this directory is not an endorsement.